Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PRCT · NASDAQ · Surgical & Medical Instruments & Apparatus
$24.70−1.05 (−4.08%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Procept Biorobotics (PRCT) · oqro.io/stocks/PRCT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 6, 2026 · Filed Nov 6, 2026
Officer sold ~$93K of PRCT shares in the open marketSourcePlanned sale · Planned for Nov 6, 2026 · Notice filed Nov 6, 2026
Officer filed to sell about $93K of PRCT stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Divisadero Street Capital Management, LP disclosed a reduced position in PRCT for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Divisadero Street Capital Management, LP disclosed a new position in PRCT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bellevue Group AG disclosed a reduced position in PRCT for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Bellevue Group AG disclosed an increased position in PRCT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC no longer reported PRCT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
Westfield Capital Management Co LP no longer reported PRCT for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Bellevue Group AG disclosed a reduced position in PRCT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Westfield Capital Management Co LP disclosed an increased position in PRCT for Q3 2025SourceInsider trade · Traded Aug 13, 2025 · Filed Aug 14, 2025
Director purchased ~$785K of PRCT shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Eventide Asset Management, LLC disclosed an increased position in PRCT for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Bellevue Group AG disclosed an increased position in PRCT for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Westfield Capital Management Co LP disclosed an increased position in PRCT for Q2 2025Insider trade · Traded Jun 12, 2025 · Filed Jun 12, 2025
Director sold ~$1.22M of PRCT shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Jun 12, 2025
Director sold ~$1.18M of PRCT shares in the open marketSourceInsider trade · Traded Jun 11, 2025 · Filed Jun 12, 2025
Director sold ~$730K of PRCT shares in the open marketSourceInsider trade · Traded Jun 11, 2025 · Filed Jun 12, 2025
Director sold ~$487K of PRCT shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Eventide Asset Management, LLC disclosed an increased position in PRCT for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Bellevue Group AG disclosed a reduced position in PRCT for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Apr 24, 2025
Perpetual Ltd no longer reported PRCT for Q1 2025SourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
CEO sold ~$312K of PRCT shares in the open marketSourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
CFO sold ~$42K of PRCT shares in the open marketSourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
Officer sold ~$18K of PRCT shares in the open marketSourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
Officer sold ~$14K of PRCT shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Bellevue Group AG disclosed a reduced position in PRCT for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in PRCT for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Westfield Capital Management Co LP disclosed a reduced position in PRCT for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Jan 17, 2025
Perpetual Ltd disclosed a new position in PRCT for Q4 2024SourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
CEO sold ~$1.34M of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
CEO sold ~$510K of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
CEO sold ~$503K of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
Officer sold ~$1.57M of PRCT shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
CEO sold ~$1.47M of PRCT shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
CEO sold ~$931K of PRCT shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
CEO sold ~$47K of PRCT shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$975K of PRCT shares in the open marketSourceInsider trade · Traded Oct 30, 2024 · Filed Oct 31, 2024
CEO sold ~$26.2M of PRCT shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
CFO sold ~$1.15M of PRCT shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
CFO sold ~$593K of PRCT shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
CFO sold ~$68K of PRCT shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC no longer reported PRCT for Q1 2025SourceInsider trade · Traded Jun 11, 2025 · Filed Jun 12, 2025
Director sold ~$367K of PRCT shares in the open marketSourceInsider trade · Traded Jun 12, 2025 · Filed Jun 12, 2025
Director sold ~$315K of PRCT shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Jun 12, 2025
Director sold ~$307K of PRCT shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Jun 12, 2025
Director sold ~$112K of PRCT shares in the open marketSourceInsider trade · Traded Jun 6, 2025 · Filed Jun 6, 2025
Officer sold ~$783K of PRCT shares in the open marketSourceInsider trade · Traded Jun 6, 2025 · Filed Jun 6, 2025
Officer sold ~$382K of PRCT shares in the open marketSourceInsider trade · Traded Jun 4, 2025 · Filed Jun 6, 2025
Director sold ~$998K of PRCT shares in the open marketSourceInsider trade · Traded Jun 6, 2025 · Filed Jun 6, 2025
Officer sold ~$118K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$817K of PRCT shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 6, 2025
Director sold ~$710K of PRCT shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 6, 2025
Director sold ~$595K of PRCT shares in the open marketSourceInsider trade · Traded Jun 4, 2025 · Filed Jun 6, 2025
Director sold ~$528K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$382K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$264K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$108K of PRCT shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 6, 2025
Director sold ~$94K of PRCT shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 6, 2025
Director sold ~$65K of PRCT shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 6, 2025
Director sold ~$52K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$43K of PRCT shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Director sold ~$6.7K of PRCT shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
CEO sold ~$976K of PRCT shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
CFO sold ~$225K of PRCT shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
Officer sold ~$223K of PRCT shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
Officer sold ~$220K of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
CEO sold ~$221K of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
Officer sold ~$795K of PRCT shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
Officer sold ~$364K of PRCT shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Dec 2, 2024
CEO sold ~$1.76M of PRCT shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Dec 2, 2024
CEO sold ~$515K of PRCT shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Dec 2, 2024
CEO sold ~$165K of PRCT shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Dec 2, 2024
CEO sold ~$140K of PRCT shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$893K of PRCT shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$431K of PRCT shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
CEO sold ~$187K of PRCT shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Bellevue Group AG disclosed a reduced position in PRCT for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed an increased position in PRCT for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Westfield Capital Management Co LP disclosed a new position in PRCT for Q3 2024SourceInsider trade · Traded Nov 6, 2024 · Filed Nov 8, 2024
Director sold ~$1.67M of PRCT shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 8, 2024
Director sold ~$1.55M of PRCT shares in the open marketSourceInsider trade · Traded Nov 5, 2024 · Filed Nov 8, 2024
Director sold ~$1.13M of PRCT shares in the open marketSourceInsider trade · Traded Nov 5, 2024 · Filed Nov 8, 2024
Director sold ~$1.12M of PRCT shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 8, 2024
Director sold ~$983K of PRCT shares in the open marketSourceInsider trade · Traded Nov 6, 2024 · Filed Nov 8, 2024
Director sold ~$900K of PRCT shares in the open marketSourceInsider trade · Traded Nov 5, 2024 · Filed Nov 8, 2024
Director sold ~$722K of PRCT shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 8, 2024
Director sold ~$660K of PRCT shares in the open marketSourceInsider trade · Traded Nov 6, 2024 · Filed Nov 8, 2024
Director sold ~$370K of PRCT shares in the open marketSourceInsider trade · Traded Nov 6, 2024 · Filed Nov 8, 2024
Director sold ~$259K of PRCT shares in the open marketSourceInsider trade · Traded Nov 5, 2024 · Filed Nov 8, 2024
Director sold ~$216K of PRCT shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 8, 2024
Director sold ~$49K of PRCT shares in the open marketSource